Free Trial

Alzamend Neuro (ALZN) SEC Filings & 10K Form

Alzamend Neuro logo
$1.19 +0.03 (+2.59%)
Closing price 04:00 PM Eastern
Extended Trading
$1.19 0.00 (0.00%)
As of 06:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Alzamend Neuro SEC Filings

DateFilerForm TypeView
12/12/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
5:01 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
4:20 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
07/30/2024
5:00 AM
Alzamend Neuro (Filer)
Form NT 10-K
07/12/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
7:52 AM
Alzamend Neuro (Filer)
Form 424B3
07/09/2024
11:15 PM
Alzamend Neuro (Filer)
Form EFFECT
07/08/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
3:31 PM
Alzamend Neuro (Filer)
Form S-1/A
06/26/2024
3:46 PM
Alzamend Neuro (Filer)
Form S-1/A
06/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form DEFA14A
06/03/2024
3:30 PM
Alzamend Neuro (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/22/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
3:30 PM
Alzamend Neuro (Issuer)
McGrath Lynne Fahey (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
05/10/2024
4:06 PM
Alzamend Neuro (Filer)
Form PRE 14A
05/10/2024
5:30 AM
Alzamend Neuro (Filer)
Form 424B5
05/09/2024
3:20 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:31 PM
Alzamend Neuro (Filer)
Form DEFA14A
04/23/2024
7:00 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:00 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:27 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/22/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:30 PM
Alzamend Neuro (Filer)
Form NT 10-Q
03/13/2024
3:30 PM
Alzamend Neuro (Filer)
Form PRE 14A
03/07/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:38 PM
Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
Form SC 13D/A
02/02/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:30 PM
Alzamend Neuro (Filer)
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:20 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:21 PM
Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALZN) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners